Officials In New York Subpoena Financial Records From Firms Tied To Sacklers
New York and some other states have alleged that as reports grew about Purdue Pharma’s marketing of OxyContin, the Sackler family began transferring money out of Purdue into a far-flung network of surrogate companies and foundations.
The New York Times:
New York Subpoenas Banks And Financial Advisers For Sackler Records
The New York state attorney general has begun issuing subpoenas to 33 financial institutions and investment advisers with ties to the Sackler family, part of an aggressive effort to track billions of dollars that prosecutors claim the family siphoned out of Purdue Pharma to hide profits gained from the company’s opioid painkillers. (Rabin, 8/15)
The New York Times:
The Weekly: A Secret Opioid Memo That Could Have Slowed An Epidemic
A confidential government document containing evidence so critical it had the potential to change the course of an American tragedy was kept in the dark for more than a decade. The document, known as a “prosecution memo,” details how government lawyers believed that Purdue Pharma, the maker of the powerful opioid, OxyContin, knew early on that the drug was fueling a rise in abuse and addiction. They also gathered evidence indicating that the company’s executives had misled the public and Congress.“ The Weekly” shines a light on that 2006 Justice Department memo and its consequences for today’s wave of lawsuits against opioid makers and members of the Sackler family, which owns Purdue Pharma. (8/16)
The Associated Press:
OxyContin Maker Purdue Agrees To Provide Research Data
The maker of the powerful painkiller OxyContin has agreed to provide access to proprietary research and other data to researchers at Oklahoma State University to help them find causes and treatments for drug addiction. Stamford, Connecticut-based Purdue Pharma announced the agreement Thursday in a joint statement with the university. (8/15)
Los Angeles Times:
Purdue Pharma Sought To Divert Online Readers From Critical L.A. Times Series On Opioid Crisis, Records Show
Internal documents from 2016 show company officials discussed diverting online traffic away from a series of stories published by the Los Angeles Times that detailed the company’s marketing of OxyContin and its links to the deadly opioid crisis. ... The documents describing Purdue’s strategy were filed earlier in the day in U.S. District Court in Cleveland by attorneys for Cuyahoga and Stark counties in Ohio. They are among more than 1,500 governments and other entities that have sued key players in the opioid epidemic to recover their costs for services and other damages stemming from the addiction crisis. (Christensen, 8/15)
